Pharmacodynamic effects of subinhibitory antibiotic concentrations

International Journal of Antimicrobial Agents

Volumn 17, Issue 1, 2001, Pages 1-8

  Odenholt, Inga ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Phamacodynamics; Postantibiontic sub MIC effect; Postantibiotic effect; Sub inhibitory minimum inhibitory concentration

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ASPOXICILLIN; AZITHROMYCIN; CEFCANEL; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; DALFOPRISTIN; ERTAPENEM; ERYTHROMYCIN; IMIPENEM; ISEPAMICIN; LENAPENEM; LEVOFLOXACIN; MEROPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; ROXITHROMYCIN; SANFETRINEM; SPARFLOXACIN; TEICOPLANIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; BACTERIAL GROWTH; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; REVIEW;

EID: 0035178339     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00243-0     Document Type: Review

References (54)

1. Dosage schedules of antimicrobial agents: A historical review
2. Pharmacokinetic/pharmacodynamic parameters: The rationale for antibacterial dosing in mice and men
3. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance
4. The treatment of lobar pneumonia and pneumococcal empyema with penicillin
5. Penicillin therapy with prolonged interval dosage schedules
6. Continuous vs. discontinuous therapy with penicillin. The effect of the interval between injections on therapeutic efficacy
7. Persistent effects of antibiotics on Staphylococcus aureus after exposure for limited periods of time
8. The recovery period following exposure of bacteria to penicillin
9. In vivo postantibiotic effect in a thigh infection in neutropenic mice
10. An in vivo model for evaluation of the postantibiotic effect
11. The postantibiotic effect
12. The rate of bacterial action of penicillin in vitro as a function of its concentration and its paradoxically reduced activity at high concentrations against certain organisms
13. Effect of antibiotic protein binding on the killing rate of Staphylococcus aureus and on the paradoxical phenomenon
14. Pharmacodynamic effects of subinihibitory concentrations in vitro
15. Effect of low antibiotic concentrations on bacteria: Effects on ultrastructure, virulence, and susceptibility to immunodefenses
16. Morphological effects of penicillin on bacteria
17. Blood cultures showing aberrant forms of bacteria
18. Aberrant forms of Pseudomonas aeruginosa in sputum and in cerebrospinal fluid causing infection in compromised patients
19. The spirocheticidal action of penicillin in vitro and its temperature coefficient
20. Penicillin: Its antibacterial effect in whole blood and serum for hemolytic streptococci and Staphylococcus aureus
21. Abnormal forms of bacteria produced by antibiotics
22. Effects of supra- and sub-MIC benzylpenicillin concentrations on group A β-hemolytic streptococci during the postantibiotic phase in vivo
23. Effects of subminimal inhibitory concentrations in experimental infections
24. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leucopenic rats
25. Effects of ten milligrams of ampicillin per day on urinary tract infections
26. Subinihibitory concentrations of antibiotics
27. Postantibiotic leucocyte enhancement: Increased susceptibility of bacteria pretreated with antibiotics to activity leucocytes
28. Antibiotics and phagocytosis
29. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface
30. The bactericidal action of penicillin in vivo: The participation of the host and the slow recovery of the surviving organisms
31. Postantibiotic effect of imipenem on Pseudomonas aeruginosa
32. Newly made enzymes determine ongoing cell wall synthesis inhibitors
33. Effects of benzylpenicillin on group A β-hemolytic streptococci during the postantibiotic phase in vitro
34. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus
35. A new method to determine postantibiotic effect and effects of subinihibitory antibiotic concentrations
36. Postantibiotic effect of Sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci
37. In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against Gram-positive and Gram-negative bacteria
38. In vivo and in vitro study of several pharmacodynamic effects of meropenem
39. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem
40. Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria
41. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin
42. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis
43. Postantibiotic effect of teicoplanin
44. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin and clarithromycin against 20 pneumococci
45. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin and azithromycin on respiratory tract pathogens
46. Comparison of the postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae
47. Postantibiotic effect and postantibiotic effects of subinihibitory concentrations of sparfloxacin on Gram-negative bacteria
48. Postantibiotic effect of trovafloxacin against Gram-positive and -negative organisms
49. Postantibiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli
50. Postantibiotic effect and postantibiotic sub-MIC effect of quinopristin-dalfopristin against Gram-positive and -negative organisms
51. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: Preliminary observations on the postantibiotic effect in vivo
52. The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits
53. Correlation between in vitro and in vivo activity of antimicrobial agents against Gram-negative bacilli in a murine infection model
54. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model